Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.

Lidegaard Ø, Nielsen LH, Skovlund CW, Skjeldestad FE, Løkkegaard E.

BMJ. 2011 Oct 25;343:d6423. doi: 10.1136/bmj.d6423.

2.

Hormonal contraception and risk of venous thromboembolism: national follow-up study.

Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C.

BMJ. 2009 Aug 13;339:b2890. doi: 10.1136/bmj.b2890.

3.

Population-based study of risk of venous thromboembolism associated with various oral contraceptives.

Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR.

Lancet. 1997 Jan 11;349(9045):83-8.

PMID:
8996419
4.
6.

Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.

Lidegaard O, Nielsen LH, Skovlund CW, Løkkegaard E.

BMJ. 2012 May 10;344:e2990. doi: 10.1136/bmj.e2990.

9.

Combined oral contraceptives: venous thrombosis.

de Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM.

Cochrane Database Syst Rev. 2014 Mar 3;(3):CD010813. doi: 10.1002/14651858.CD010813.pub2. Review.

PMID:
24590565
10.
11.

Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies.

Shapiro S, Dinger J.

J Fam Plann Reprod Health Care. 2010 Jan;36(1):33-8. doi: 10.1783/147118910790291037. Review.

12.
13.

Smoking and use of oral contraceptives: impact on thrombotic diseases.

Lidegaard O.

Am J Obstet Gynecol. 1999 Jun;180(6 Pt 2):S357-63.

PMID:
10368521
14.
15.

The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

Lewis MA, Heinemann LA, MacRae KD, Bruppacher R, Spitzer WO.

Contraception. 1996 Jul;54(1):5-13. Erratum in: Contraception 1996 Aug;54(2):121.

PMID:
8804801
17.

Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.

Dinger J, Assmann A, Möhner S, Minh TD.

J Fam Plann Reprod Health Care. 2010 Jul;36(3):123-9. doi: 10.1783/147118910791749416.

19.

Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.

Heinemann K, Heinemann LA.

J Fam Plann Reprod Health Care. 2011 Jul;37(3):132-5. doi: 10.1136/jfprhc-2011-14524. Epub 2011 Jun 9. No abstract available.

PMID:
21659330
20.

Estrogen and progestin components of oral contraceptives: relationship to vascular disease.

Carr BR, Ory H.

Contraception. 1997 May;55(5):267-72. Review.

PMID:
9220222

Supplemental Content

Support Center